Form 4: Clover Health CEO Andrew Toy Reports Routine Tax Withholding on RSU Vesting
Insider Transaction Report
Clover Health Investments, Corp. CEO Andrew Toy reported the automatic withholding of 308,950 Class A Common Stock shares to cover tax obligations related to the vesting of restricted stock units.
Summary
- Andrew Toy, Chief Executive Officer and Director of Clover Health Investments, Corp. (CLOV), reported a transaction on July 1, 2025.
- The transaction involved the disposition of 308,950 shares of Class A Common Stock.
- These shares were automatically withheld to cover tax obligations arising from the vesting of restricted stock units (RSUs).
- The shares were valued at $2.75 for the purpose of this tax withholding.
- Following this transaction, Andrew Toy beneficially owns 10,560,047 shares of Class A Common Stock.
- This withholding corresponds to the vesting of 6.25% of the original RSUs granted on January 1, 2023.
- Remaining RSUs will vest quarterly in equal 6.25% installments, with the final vesting on January 1, 2027, contingent on continued service.
Sentiment
Score: 5
Explanation: The transaction is a routine tax withholding related to RSU vesting, which is a neutral event and does not indicate positive or negative sentiment about the company's performance or outlook.
Future Outlook
Remaining restricted stock units granted to Andrew Toy are scheduled to vest quarterly in equal installments of 6.25%, with the final vesting occurring on January 1, 2027, contingent on his continued service.
Industry Context
This filing represents a routine insider transaction related to equity compensation, common across publicly traded companies, particularly in the healthcare technology sector where attracting and retaining executive talent often involves significant equity grants.
Stakeholder Impact
- Shareholders: The transaction represents a minor dilution from RSU vesting, but it is a standard part of executive compensation and tax obligations, not indicative of a significant change in company value or strategy.
Next Steps
- Continued quarterly vesting of remaining restricted stock units in 6.25% installments until January 1, 2027.
Key Dates
| Date | Description |
|---|---|
| January 1, 2023 | Original grant date of restricted stock units (RSUs) to Andrew Toy. |
| January 4, 2023 | Date of the Form 4 filing reporting the original RSU grant. |
| July 1, 2025 | Transaction date for the automatic withholding of shares to cover tax obligations due to RSU vesting. |
| July 3, 2025 | Signature date of the Form 4 filing. |
| January 1, 2027 | Final vesting date for remaining restricted stock units. |
Keywords
Clover Health, CLOV, Andrew Toy, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Tax Withholding, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.